ARE THERE DIFFERENCES IN BASAL COMORBIDITIES BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT AND THOSE TREATED WITH TUMOR NECROSIS FACTOR INHIBITORS? Conference Poster 2016 Congress communication